MedTrace Logo

Protein Hydrolyzation and Glycemic Control

NCT01034618 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL

Last updated 2009-12-17

No results posted yet for this study

Summary

The insulinotropic effects of protein hydrolysate/amino acid ingestion have been shown to regulate blood glucose homeostasis in both type 2 diabetes patients and normoglycemic controls. The objective of the study is to investigate the optimal dose of such an insulinotropic mixture.

Conditions

Interventions

DIETARY_SUPPLEMENT

Protein hydrolyzation

Sponsors & Collaborators

  • Maastricht University Medical Center

    lead OTHER

Study Design

Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
40 Years
Max Age
70 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-12-31
Primary Completion
2008-10-31
Completion
2009-04-30

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01034618 on ClinicalTrials.gov